Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors

This project intends to investigate the clinical efficacy of intra-tumoural injection of chemotherapeutic agents (e.g. cisplatin, oxaliplatin, etc.)via fine needle aspiration guided by CT or ultrasound in patients with advanced solid cancers to validate the safety and efficacy.

Participants needed: 200
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Wuxi People's HospitalUpdated: May 28, 2024Locations: 1
Eligibility criteria

Male or female aged 18-75 years; [+5]

The patient is diagnosed with central nervous system leukemia(symptoms, signs, i... [+9]

Status: Recruiting

Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours

This study is intended to investigate the clinical efficacy of TTV vaccine combined with PD-1/PD-L1 inhibitor in the treatment of relapsed and refractory advanced solid tumours from a clinical perspective.

Participants needed: 200
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Wuxi People's HospitalUpdated: May 28, 2024Locations: 1
Eligibility criteria

Male or female aged 18-75 years; [+5]

The patient is diagnosed with central nervous system leukemia(symptoms, signs, i... [+10]

Status: Recruiting

Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours

By controlling the patient's blood sugar, small doses of chemotherapy are used in a hypoglycemic state. Some necrotic tumor cells produced by chemotherapy can maintain their immunogenicity, further activate innate immunity, and produce very strong anticancer effects without the cytotoxic effects of chemotherapy.

Participants needed: 300
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Wuxi People's HospitalUpdated: May 8, 2024Locations: 1
Eligibility criteria

Male or female aged 18-75 years; [+5]

The patient is diagnosed with central nervous system leukemia(symptoms, signs, i... [+10]